跳至主要内容
临床试验/IRCT201108155280N5
IRCT201108155280N5已完成3 期

A comparative study on the effectiveness of Risperidone versus Risperidone plus naltrexone in treatment of autistic spectrum disorder in children with 6-12 years old

Mashhad University of Medical Scinces0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
4 years 至 12 years(—)
性别
All

入选标准

  • 1- children with 4-12 years old; 2- children with at least one of the autistic spectrum disorder signs; 3- Fill out informative consent sheet in order to include the study. Exclusion criteria: 1- Children with severe medical disorders; 2- The history of severe drug sensitivity to naltrexone or risperidone.

排除标准

  • 未提供

研究者

发起方
Mashhad University of Medical Scinces

相似试验

A comparative study on the effectiveness of... | 临床试验